CG Invites Co., Ltd. (KOSDAQ: A083790)
Health Care · Biotechnology · KR
₩902.00
-3.01% today · -40.3% 1Y
CG Invites Co., Ltd. (KOSDAQ: A083790) operates in the Biotechnology industry within the Health Care sector. The company is valued at $52.02M.
Over the last twelve months the share price has lost 40.3%, trading between 711.00 and 1.67K.
Tweenvest scores CG Invites Co., Ltd. across four factors: quality 45/100, value 44/100, growth 100/100. Its strongest factor is growth.
A083790 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $52.02M
- Revenue (TTM)
- $19.44M
- P/E
- —
- EPS
- 5.58
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- ₩1,667.00
- 52-week low
- ₩711.00
- Avg volume (3M)
- —
- Shares outstanding
- 76.89M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Helix BioPharma Corp.TSX: HBP | $52.92M | CA$0.98 | +6.52% |
| OSE Immunotherapeutics SAENXTPA: OSE | $52.78M | €2.00 | -1.86% |
| Sirnaomics Ltd.SEHK: 2257 | $52.66M | HK$3.80 | +1.34% |
| UBI Pharma Inc.UNQ: 6562 | $52.10M | NT$— | — |
| CellSeed Inc.TSE: 7776 | $51.50M | ¥206.00 | -2.37% |
| RenovoRx, Inc.NasdaqCM: RNXT | $51.45M | $1.14 | -10.94% |
| Synbio Tech Inc.TPEX: 1295 | $51.37M | NT$48.35 | -3.49% |
| Prestige BioPharma LimitedKOSE: A950210 | $51.30M | ₩5,690.00 | -4.53% |
Figures last refreshed Oct 18, 2026.